163 related articles for article (PubMed ID: 25645959)
1. Multifunctional ultrasmall nanoplatforms for vascular-targeted interstitial photodynamic therapy of brain tumors guided by real-time MRI.
Bechet D; Auger F; Couleaud P; Marty E; Ravasi L; Durieux N; Bonnet C; Plénat F; Frochot C; Mordon S; Tillement O; Vanderesse R; Lux F; Perriat P; Guillemin F; Barberi-Heyob M
Nanomedicine; 2015 Apr; 11(3):657-70. PubMed ID: 25645959
[TBL] [Abstract][Full Text] [Related]
2. Functionalized silica-based nanoparticles for photodynamic therapy.
Couleaud P; Bechet D; Vanderesse R; Barberi-Heyob M; Faure AC; Roux S; Tillement O; Porhel S; Guillemin F; Frochot C
Nanomedicine (Lond); 2011 Aug; 6(6):995-1009. PubMed ID: 21726134
[TBL] [Abstract][Full Text] [Related]
3. Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma.
Thomas E; Colombeau L; Gries M; Peterlini T; Mathieu C; Thomas N; Boura C; Frochot C; Vanderesse R; Lux F; Barberi-Heyob M; Tillement O
Int J Nanomedicine; 2017; 12():7075-7088. PubMed ID: 29026302
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional Peptide-conjugated hybrid silica nanoparticles for photodynamic therapy and MRI.
Benachour H; Sève A; Bastogne T; Frochot C; Vanderesse R; Jasniewski J; Miladi I; Billotey C; Tillement O; Lux F; Barberi-Heyob M
Theranostics; 2012; 2(9):889-904. PubMed ID: 23082101
[TBL] [Abstract][Full Text] [Related]
5. Vascular targeted nanoparticles for imaging and treatment of brain tumors.
Reddy GR; Bhojani MS; McConville P; Moody J; Moffat BA; Hall DE; Kim G; Koo YE; Woolliscroft MJ; Sugai JV; Johnson TD; Philbert MA; Kopelman R; Rehemtulla A; Ross BD
Clin Cancer Res; 2006 Nov; 12(22):6677-86. PubMed ID: 17121886
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different treatment schemes in 5-ALA interstitial photodynamic therapy for high-grade glioma in a preclinical model: An MRI study.
Vermandel M; Quidet M; Vignion-Dewalle AS; Leroy HA; Leroux B; Mordon S; Reyns N
Photodiagnosis Photodyn Ther; 2019 Mar; 25():166-176. PubMed ID: 30543907
[TBL] [Abstract][Full Text] [Related]
7. Proton MR Spectroscopy and Diffusion MR Imaging Monitoring to Predict Tumor Response to Interstitial Photodynamic Therapy for Glioblastoma.
Toussaint M; Pinel S; Auger F; Durieux N; Thomassin M; Thomas E; Moussaron A; Meng D; Plénat F; Amouroux M; Bastogne T; Frochot C; Tillement O; Lux F; Barberi-Heyob M
Theranostics; 2017; 7(2):436-451. PubMed ID: 28255341
[TBL] [Abstract][Full Text] [Related]
8. MRI assessment of treatment delivery for interstitial photodynamic therapy of high-grade glioma in a preclinical model.
Leroy HA; Vermandel M; Leroux B; Duhamel A; Lejeune JP; Mordon S; Reyns N
Lasers Surg Med; 2018 Jul; 50(5):460-468. PubMed ID: 29023876
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional nanoparticle PEG‑Ce6‑Gd for MRI‑guided photodynamic therapy.
Xu D; Baidya A; Deng K; Li YS; Wu B; Xu HB
Oncol Rep; 2021 Feb; 45(2):547-556. PubMed ID: 33416172
[TBL] [Abstract][Full Text] [Related]
10. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
Tirand L; Frochot C; Vanderesse R; Thomas N; Trinquet E; Pinel S; Viriot ML; Guillemin F; Barberi-Heyob M
J Control Release; 2006 Mar; 111(1-2):153-64. PubMed ID: 16423422
[TBL] [Abstract][Full Text] [Related]
11. Multiscale Selectivity and in vivo Biodistribution of NRP-1
Gries M; Thomas N; Daouk J; Rocchi P; Choulier L; Jubréaux J; Pierson J; Reinhard A; Jouan-Hureaux V; Chateau A; Acherar S; Frochot C; Lux F; Tillement O; Barberi-Heyob M
Int J Nanomedicine; 2020; 15():8739-8758. PubMed ID: 33223826
[TBL] [Abstract][Full Text] [Related]
12. New Peptide-Conjugated Chlorin-Type Photosensitizer Targeting Neuropilin-1 for Anti-Vascular Targeted Photodynamic Therapy.
Kamarulzaman EE; Gazzali AM; Acherar S; Frochot C; Barberi-Heyob M; Boura C; Chaimbault P; Sibille E; Wahab HA; Vanderesse R
Int J Mol Sci; 2015 Oct; 16(10):24059-80. PubMed ID: 26473840
[TBL] [Abstract][Full Text] [Related]
13. Photosensitizer-conjugated magnetic nanoparticles for in vivo simultaneous magnetofluorescent imaging and targeting therapy.
Huang P; Li Z; Lin J; Yang D; Gao G; Xu C; Bao L; Zhang C; Wang K; Song H; Hu H; Cui D
Biomaterials; 2011 May; 32(13):3447-58. PubMed ID: 21303717
[TBL] [Abstract][Full Text] [Related]
14. Peptide-conjugated chlorin-type photosensitizer binds neuropilin-1 in vitro and in vivo.
Thomas N; Bechet D; Becuwe P; Tirand L; Vanderesse R; Frochot C; Guillemin F; Barberi-Heyob M
J Photochem Photobiol B; 2009 Aug; 96(2):101-8. PubMed ID: 19464192
[TBL] [Abstract][Full Text] [Related]
15. 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: implications for photodynamic therapy.
Lobel J; MacDonald IJ; Ciesielski MJ; Barone T; Potter WR; Pollina J; Plunkett RJ; Fenstermaker RA; Dougherty TJ
Lasers Surg Med; 2001; 29(5):397-405. PubMed ID: 11891727
[TBL] [Abstract][Full Text] [Related]
16. Tissue distribution and pharmacokinetics of an ATWLPPR-conjugated chlorin-type photosensitizer targeting neuropilin-1 in glioma-bearing nude mice.
Thomas N; Tirand L; Chatelut E; Plénat F; Frochot C; Dodeller M; Guillemin F; Barberi-Heyob M
Photochem Photobiol Sci; 2008 Apr; 7(4):433-41. PubMed ID: 18385885
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy targeting neuropilin-1: Interest of pseudopeptides with improved stability properties.
Thomas N; Pernot M; Vanderesse R; Becuwe P; Kamarulzaman E; Da Silva D; François A; Frochot C; Guillemin F; Barberi-Heyob M
Biochem Pharmacol; 2010 Jul; 80(2):226-35. PubMed ID: 20380812
[TBL] [Abstract][Full Text] [Related]
18. Fluorescent diagnosis and photodynamic therapy for C6 glioma in combination with antiangiogenic therapy in subcutaneous and intracranial tumor models.
Tzerkovsky DA; Osharin VV; Istomin YP; Alexandrova EN; Vozmitel MA
Exp Oncol; 2014 Jun; 36(2):85-9. PubMed ID: 24980761
[TBL] [Abstract][Full Text] [Related]
19. Silica-based nanoparticles for photodynamic therapy applications.
Couleaud P; Morosini V; Frochot C; Richeter S; Raehm L; Durand JO
Nanoscale; 2010 Jul; 2(7):1083-95. PubMed ID: 20648332
[TBL] [Abstract][Full Text] [Related]
20. Tumor acidity-activatable TAT targeted nanomedicine for enlarged fluorescence/magnetic resonance imaging-guided photodynamic therapy.
Gao M; Fan F; Li D; Yu Y; Mao K; Sun T; Qian H; Tao W; Yang X
Biomaterials; 2017 Jul; 133():165-175. PubMed ID: 28437627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
